Assignee
DELMAR PHARMACEUTICALS INC
CA·8 granted patents·4 pending applications·11 citations·filing 2013–2018
Top patents by PatentIndex Score
12 records- 0185US9901563B2Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Feb 27, 2018·2 cites·10 claims
- 0281US9687466B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiformeDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·5 cites·42 claims
- 0372US9814693B2Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignanciesDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Nov 14, 2017·2 cites·5 claims
- 0471US11446274B2Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2016·Granted Sep 20, 2022·1 cites·4 claims
- 0562US11026914B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumorDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jun 8, 2021·1 cites·8 claims
- 0658US2017266150A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastomaDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0758US2018147178A1Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0857US10145824B2Analytical methods for analyzing and determining impurities in dianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Dec 4, 2018·0 cites·42 claims
- 0955US11541027B2Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastasesDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jan 3, 2023·0 cites·33 claims
- 1053US2019183843A9Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1152US9630938B2Method of synthesis of substituted hexitols such as dianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Apr 25, 2017·0 cites·27 claims
- 1229US2019015379A1Use of dianhydrogalactitol and analogs and derivatives thereof, together with radiation, to treat non-small-cell carcinoma of the lung and glioblastoma multiforme and suppress proliferation of cancer stem cellsDELMAR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DELMAR PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →